Read + Share
Maddalena G, van der Pol Y, Villarreal OE, Coker O, et al. Impact of KRAS codon-specific mutations on survival in metastatic CRC on
trifluridine-tipiracil with/without bevacizumab. J Natl Cancer Inst 2026;118:903-908.
PMID: 41455083
|
 |
|
Maddalena G, van der Pol Y, Villarreal OE, Coker O, et al. Impact of KRAS codon-specific mutations on survival in metastatic CRC on
trifluridine-tipiracil with/without bevacizumab. J Natl Cancer Inst 2026;118:903-908.
PMID: 41455083
|
|
|
|